Skip to content

Sterop Overseas: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Sterop Overseas

BE 0419.184.411
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€481,216
2024 · €1.0m-€550,288
Equity
€2.3m
2024 · €2.3m+€1,216
Cash
€1.3m
2024 · €87,657+€1.2m
Balance sheet total
€4.1m
2024 · €5.2m-€1.2m

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€2.3m

    down €2.3m (-58.5%), from €3.9m to €1.6m

    of which Trade receivables: -€2.4m

  • Cash +€1.2m

    up €1.2m (+1,346%), from €87,657 to €1.3m

    mainly Receivables within one year (+€2.3m) and Net result for the year (+€481,216)

Equity and liabilities
  • Trade debts -€681,760

    down €681,760 (-76.1%), from €895,525 to €213,765

  • Other debts -€472,719

    down €472,719 (-37.8%), from €1.3m to €778,311

Income statement
  • Gross operating margin -€937,318

    down €937,318 (-50.1%), from €1.9m to €931,763

  • Taxes -€196,762

    down €196,762 (-53.7%), from €366,617 to €169,855

  • Financial charges -€131,081

    no longer reported in 2025 (was €131,081)

  • Write-downs -€48,750

    no longer reported in 2025 (was €48,750)

  • Financial income +€47,491

    up €47,491 (+2,827%), from €1,680 to €49,171

    of which Financial income: +€43,301

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €1.0m
Gross operating margin -€937,318
Staff costs +€19,165
Depreciation +€3,744
Write-downs +€48,750
Other operating charges +€14,872
Other operating items -€74,835
Financial income +€47,491
Financial charges +€131,081
Taxes +€196,762
Result 2025 €481,216
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€1.7m
Investment €0
Financing -€480,000
Cash 2024 €87,657
Net result for the year +€481,216
Depreciation +€4,296
Stocks and contracts +€37,607
Receivables within one year +€2.3m
Deferred charges and accrued income +€33,333
Trade debts -€681,760
Tax, wage and social debts +€12,313
Other debts -€472,719
Accrued charges and deferred income -€13,352
Contributions, distributions and other -€480,000
Cash 2025 €1.3m
brings cash intakes cash out
Every line side by side 52 lines
Line Code 2024 2025 Change %
Total assets 20/58 €5,229,189 €4,074,887 -€1.2m -22.1%
Fixed assets 21/28 €1,206,182 €1,201,886 -€4,296 -0.4%
Tangible fixed assets 22/27 €5,908 €1,612 -€4,296 -72.7%
Plant, machinery and equipment 23 €5,908 €1,612 -€4,296 -72.7%
Financial fixed assets 28 €1,200,274 €1,200,274 = 0.0%
Current assets 29/58 €4,023,007 €2,873,001 -€1.2m -28.6%
Stocks and contracts in progress 3 €37,607 - -€37,607
Stocks 30/36 €37,607 - -€37,607
Amounts receivable within one year 40/41 €3,864,410 €1,605,443 -€2.3m -58.5%
Trade receivables 40 €3,760,422 €1,397,229 -€2.4m -62.8%
Other amounts receivable 41 €103,988 €208,214 +€104,226 +100%
Cash at bank and in hand 54/58 €87,657 €1,267,558 +€1.2m +1,346%
Deferred charges and accrued income 490/1 €33,333 - -€33,333
Total equity and liabilities 10/49 €5,229,189 €4,074,887 -€1.2m -22.1%
Equity 10/15 €2,347,292 €2,348,508 +€1,216 +0.1%
Contributions 10/11 €80,000 €80,000 = 0.0%
Capital 10 €80,000 €80,000 = 0.0%
Issued capital 100 €80,000 €80,000 = 0.0%
Reserves 13 €3,098,296 €3,098,296 = 0.0%
Non-distributable reserves 130/1 €8,496 €8,496 = 0.0%
Legal reserve 130 €8,000 €8,000 = 0.0%
Other 1319 €496 €496 = 0.0%
Distributable reserves 133 €3,089,800 €3,089,800 = 0.0%
Profit (loss) carried forward 14 -€831,004 -€829,788 +€1,216 +0.1%
Amounts payable 17/49 €2,881,897 €1,726,379 -€1.2m -40.1%
Amounts payable within one year 42/48 €2,803,546 €1,661,380 -€1.1m -40.7%
Financial debts 43 €350,000 €350,000 = 0.0%
Credit institutions 430/8 €350,000 €350,000 = 0.0%
Trade debts 44 €895,525 €213,765 -€681,760 -76.1%
Suppliers 440/4 €895,525 €213,765 -€681,760 -76.1%
Advances received on contracts in progress 46 €147,420 €147,420 = 0.0%
Taxes, remuneration and social security 45 €159,571 €171,884 +€12,313 +7.7%
Taxes 450/3 €130,561 €160,599 +€30,038 +23.0%
Remuneration and social security 454/9 €29,010 €11,285 -€17,725 -61.1%
Other amounts payable 47/48 €1,251,030 €778,311 -€472,719 -37.8%
Accrued charges and deferred income 492/3 €78,351 €64,999 -€13,352 -17.0%
Remuneration, social security and pensions 62 €265,575 €246,410 -€19,165 -7.2%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €8,040 €4,296 -€3,744 -46.6%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 €48,750 - -€48,750
Other operating charges 640/8 €19,194 €4,322 -€14,872 -77.5%
Non-recurring operating charges 66A - €74,835 +€74,835
Gross operating margin 9900 €1,869,081 €931,763 -€937,318 -50.1%
Operating profit (loss) 9901 €1,527,522 €601,900 -€925,622 -60.6%
Financial income 75/76B €1,680 €49,171 +€47,491 +2,827%
Recurring financial income 75 €1,680 €44,981 +€43,301 +2,577%
Non-recurring financial income 76B - €4,190 +€4,190
Financial charges 65/66B €131,081 - -€131,081
Recurring financial charges 65 €131,081 - -€131,081
Profit (loss) for the period before taxes 9903 €1,398,121 €651,071 -€747,050 -53.4%
Income taxes 67/77 €366,617 €169,855 -€196,762 -53.7%
Profit (loss) for the period 9904 €1,031,504 €481,216 -€550,288 -53.3%
Profit (loss) for the period to be appropriated 9905 €1,031,504 €481,216 -€550,288 -53.3%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.